ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

XRTX XORTX Therapeutics Inc

2.93
0.34 (13.13%)
Apr 26 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
XORTX Therapeutics Inc XRTX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.34 13.13% 2.93 15:59:59
Open Price Low Price High Price Close Price Previous Close
2.75 2.5301 3.00 2.93 2.59
more quote information »

Recent News

Date Time Source Heading
4/22/202406:00GLOBEXORTX Announces Publication of Key Research in ADPKD
4/08/202406:30GLOBEXORTX Welcomes New Member to the Board of Directors
4/08/202406:00GLOBEXORTX Announces Participation in Spring 2024 Investor..
3/27/202404:00GLOBEXORTX Announces New Clinical Advisory Board Member
3/19/202404:00GLOBEXORTX Highlights Achievements of 2023 and Preparation for..
3/11/202406:00GLOBEXORTX Reprices Warrants Issued in Connection with Previous..
3/04/202406:00GLOBEXORTX Finalizes $2.7 Million Prospectus Supplement and..
2/15/202406:00GLOBEXORTX Raises $2.5 Million Under Prospectus Supplement and..
2/01/202419:46GLOBEXORTX Files an Amended and Restated Prospectus Supplement..
1/15/202406:00GLOBEXORTX Announces $2 Million Public Offering
1/03/202406:25EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/03/202406:00GLOBEXORTX Submits a New Patent for the Treatment of Chronic..
1/02/202407:12EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/02/202406:00GLOBEXORTX Welcomes New Member to the Board of Directors
11/30/202315:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/30/202306:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/30/202306:30GLOBEXORTX Announces US ATM Offering
11/29/202320:57EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/29/202306:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/29/202306:00GLOBEXORTX Meets Nasdaq Continued Listing Requirements
11/13/202306:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/10/202306:00GLOBEXORTX Clarifies Timing for Share Consolidation
11/08/202316:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/08/202316:00GLOBEXORTX Announces Share Consolidation
11/02/202306:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/02/202306:00GLOBEXORTX Sponsored Study Presented at the American Society of..
10/27/202316:30GLOBEXORTX Announces Results of Special Meeting of Shareholders
10/25/202316:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/25/202316:00GLOBEXORTX Announces Date for Rescheduled Special Meeting of..
10/25/202306:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/25/202306:00GLOBEXORTX Announces Rescheduling of Special Meeting of..
10/12/202306:41EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/12/202306:00GLOBEXORTX Reports that Independent Proxy Firm, ISS, Recommends..
10/04/202312:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/04/202306:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/04/202306:00GLOBEXORTX Calls Special Meeting of Shareholders
9/28/202306:56EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/28/202306:00GLOBEXORTX Sponsored Study Selected for Presentation at the..
9/12/202314:56EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/11/202306:00GLOBEXORTX Announces Participation at Upcoming Investor..
9/07/202307:23EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/07/202306:00GLOBEXORTX Joins the Kidney Foundation and Kidney March
8/29/202306:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/29/202306:00GLOBEXORTX Submits Orphan Drug Designation Application to the..
8/25/202305:00EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
8/14/202315:42EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
8/14/202315:40EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
8/07/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
8/04/202316:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/04/202316:00GLOBEXORTX Appoints Chief Financial Officer

Your Recent History

Delayed Upgrade Clock